Female sex steroids and epilepsy: Part 2. A practical and human focus on catamenial epilepsy
Epilepsia · 2024
DOI: 10.1111/epi.17820 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Epilepsia, 2024. Verfasst von Malak Alshakhouri und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy, Reflex. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Maurice and Phyllis Paykel Trust, Neurological Foundation of New Zealand.
Abstract (Originalsprache)
Catamenial epilepsy is the best described and most researched sex steroid‐specific seizure exacerbation. Yet despite this there are no current evidence‐based treatments, nor an accepted diagnostic tool. The best tool we currently have is tracking seizures over menstrual cycles; however, the reality of tracking seizures and menstrual cycles is fraught with challenges. In Part 1 of this two‐part review, we outlined the often complex and reciprocal relationship between seizures and sex steroids. An adaptable means of tracking is required. In this review, we outline the extent and limitations of current knowledge on catamenial epilepsy. We use sample data to show how seizure exacerbations can be tracked in short/long and even irregular menstrual cycles. We describe how seizure severity, an often overlooked and underresearched form of catamenial seizure exacerbation, can also be tracked. Finally, given the lack of treatment options for females profoundly affected by catamenial epilepsy, Section 3 focuses on current methods and models for researching sex steroids and seizures as well as limitations and future directions. To permit more informative, mechanism‐focused research in humans, the need for both a consistent classification of catamenial epilepsy and an objective biomarker is highlighted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, University of Auckland, Auckland, New Zealand.
- Department of Paediatric Neurology, Starship Children's Health, Auckland, New Zealand.
- Neurology Department, Auckland Hospital, Te Whatu Ora, Auckland, New Zealand.
ORCID-Profile: Malak Alshakhouri, Cynthia Sharpe, Peter Bergin, Rachael L Sumner
Förderung
- Maurice and Phyllis Paykel Trust
- Neurological Foundation of New Zealand
Zitieren
APA
Alshakhouri, M., Sharpe, C., Bergin, P., & Sumner, R. L. (2024). Female sex steroids and epilepsy: Part 2. A practical and human focus on catamenial epilepsy. Epilepsia. https://doi.org/10.1111/epi.17820
Vancouver
Alshakhouri M, Sharpe C, Bergin P, Sumner RL. Female sex steroids and epilepsy: Part 2. A practical and human focus on catamenial epilepsy. Epilepsia. 2024. doi:10.1111/epi.17820
BibTeX
@article{Alshakhouri2024,
author = {Alshakhouri, Malak and Sharpe, Cynthia and Bergin, Peter and Sumner, Rachael L},
title = {Female sex steroids and epilepsy: Part 2. A practical and human focus on catamenial epilepsy},
journal = {Epilepsia},
year = {2024},
doi = {10.1111/epi.17820}
}
EUVIMED